SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. Peck-Radosavljevic, Editorial: dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma, Alimentary Pharmacology & Therapeutics, 2015, 41, 11
  2. 2
    Carlo Smirne, Glenda Grossi, David J. Pinato, Michela E. Burlone, Francesco A. Mauri, Adam Januszewski, Alberto Oldani, Rosalba Minisini, Rohini Sharma, Mario Pirisi, Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma, Digestive and Liver Disease, 2015, 47, 6, 488

    CrossRef

  3. 3
    Hayato Nakagawa, Naoto Fujiwara, Ryosuke Tateishi, Toru Arano, Ryo Nakagomi, Mayuko Kondo, Tatsuya Minami, Masaya Sato, Koji Uchino, Kenichiro Enooku, Yoshinari Asaoka, Yuji Kondo, Shuichiro Shiina, Haruhiko Yoshida, Kazuhiko Koike, Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients, Journal of Gastroenterology and Hepatology, 2015, 30, 2
  4. 4
    Wayland Hsiao, Lindsey A Herrel, Changhong Yu, Michael W Kattan, Daniel J Canter, Bradley C Carthon, Kenneth Ogan, Viraj A Master, Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma, International Journal of Urology, 2015, 22, 3
  5. 5
    Philipp Schwabl, Theresa Bucsics, Kathrin Soucek, Mattias Mandorfer, Simona Bota, Alexander Blacky, Alexander M. Hirschl, Arnulf Ferlitsch, Michael Trauner, Markus Peck-Radosavljevic, Thomas Reiberger, Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites, Liver International, 2015, 35, 7
  6. 6
    Xiao-Chun Ni, Yong Yi, Yi-Peng Fu, Hong-Wei He, Xiao-Yan Cai, Jia-Xing Wang, Jian Zhou, Jia Fan, Shuang-Jian Qiu, Serum Amyloid A is a Novel Prognostic Biomarker in Hepatocellular Carcinoma, Asian Pacific Journal of Cancer Prevention, 2015, 15, 24, 10713

    CrossRef

  7. 7
    Naoto Fujiwara, Ryosuke Tateishi, Hayato Nakagawa, Ryo Nakagomi, Mayuko Kondo, Tatsuya Minami, Masaya Sato, Koji Uchino, Kenichiro Enooku, Yuji Kondo, Yoshinari Asaoka, Shuichiro Shiina, Haruhiko Yoshida, Kazuhiko Koike, Slight elevation of high-sensitivity C-reactive protein to predict recurrence and survival in patients with early stage hepatitis C-related hepatocellular carcinoma, Hepatology Research, 2015, 45, 6
  8. 8
    D. J. Pinato, G. Karamanakos, T. Arizumi, D. Adjogatse, Y. W. Kim, J. Stebbing, M. Kudo, J. W. Jang, R. Sharma, Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study, Alimentary Pharmacology & Therapeutics, 2014, 40, 11-12
  9. 9
    Kenji Yorita, Akinobu Ohno, Hiroaki Kataoka, Emerging histopathological prognostic biomarkers in hepatocellular carcinomas, Personalized Medicine Universe, 2014, 3, 15

    CrossRef

  10. 10
    Florian Hucke, Matthias Pinter, Ivo Graziadei, Simona Bota, Wolfgang Vogel, Christian Müller, Harald Heinzl, Fredrik Waneck, Michael Trauner, Markus Peck-Radosavljevic, Wolfgang Sieghart, How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma, Journal of Hepatology, 2014, 61, 6, 1287

    CrossRef

  11. 11
    S. Pathak, Q. M. Nunes, I. R. Daniels, N. J. Smart, Is C-reactive protein useful in prognostication for colorectal cancer? A systematic review, Colorectal Disease, 2014, 16, 10
  12. 12
    A. Kornberg, Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome, ISRN Hepatology, 2014, 2014, 1

    CrossRef

  13. 13
    Abby K. Geletzke, John M. Rinaldi, Brett E. Phillips, Sarah B. Mobley, Jamie Miller, Thomas Dykes, Christopher Hollenbeak, Shannon L. Kelleher, David I. Soybel, Prevalence of Systemic Inflammation and Micronutrient Imbalance in Patients with Complex Abdominal Hernias, Journal of Gastrointestinal Surgery, 2014, 18, 4, 646

    CrossRef

  14. 14
    Waka Ohishi, John B. Cologne, Saeko Fujiwara, Gen Suzuki, Tomonori Hayashi, Yasuharu Niwa, Masazumi Akahoshi, Keiko Ueda, Masataka Tsuge, Kazuaki Chayama, Serum interleukin-6 associated with hepatocellular carcinoma risk: A nested case–control study, International Journal of Cancer, 2014, 134, 1
  15. 15
    F. Finkelmeier, B. Kronenberger, V. Köberle, J. Bojunga, S. Zeuzem, J. Trojan, A. Piiper, O. Waidmann, Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma – a prospective cohort study, Alimentary Pharmacology & Therapeutics, 2014, 39, 10
  16. 16
    Fabian Finkelmeier, Dominik Bettinger, Verena Köberle, Michael Schultheiß, Stefan Zeuzem, Bernd Kronenberger, Albrecht Piiper, Oliver Waidmann, Single measurement of hemoglobin predicts outcome of HCC patients, Medical Oncology, 2014, 31, 1

    CrossRef

  17. 17
    Akira Iwaku, Akiyoshi Kinoshita, Hiroshi Onoda, Nao Fushiya, Hirokazu Nishino, Masato Matsushima, Hisao Tajiri, The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection, Medical Oncology, 2014, 31, 1

    CrossRef

  18. 18
    Jean-François Dufour, C-reactive protein, a prognostic marker in hepatocellular carcinoma, Hepatology, 2013, 57, 6
  19. 19
    Oliver Waidmann, Verena Köberle, Dominik Bettinger, Jörg Trojan, Stefan Zeuzem, Michael Schultheiß, Bernd Kronenberger, Albrecht Piiper, Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma, Journal of Hepatology, 2013, 59, 4, 769

    CrossRef

  20. 20
    Wolfgang Sieghart, Priv. Doz. Dr. Wolfgang Sieghart Researcher of the Month Juni 2013, Wiener klinische Wochenschrift, 2013, 125, 11-12, 348

    CrossRef

  21. 21
    Wolfgang Sieghart, Florian Hucke, Matthias Pinter, Ivo Graziadei, Wolfgang Vogel, Christian Müller, Harald Heinzl, Michael Trauner, Markus Peck-Radosavljevic, The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma, Hepatology, 2013, 57, 6